YOLFTbeta
30

Chengdu Bright Eye Hospital Co. Ltd.

301239 · SHE · Healthcare / Medical Care Facilities

34.25CNY-0.60 (-1.72%)

Price History

Full chart

Market Stats

Previous Close34.85
Open35.02
Day Range34.06 – 35.07
52-Week Range28.08 – 47.87
Volume1.77M
Market Cap4.78B
P/E (TTM)399.75
Forward P/E0.00
EPS0.08
Dividend Yield0.94%
Beta0.65
50-Day Avg33.19
200-Day Avg34.88

About

Bright Eye Hospital Group Co., Ltd., together with its subsidiaries, operates ophthalmic medical institutions in China. The company offers ophthalmic diagnostic and treatment services, including refractive surgery, medical optometry and glasses fitting, cataract surgery, glaucoma treatment, strabismus and amblyopia, pediatric ophthalmology, fundus diseases treatment, oculoplastic surgery, lacrimal duct surgery, and corneal diseases treatment, as well as low vision and visual rehabilitation. It is also involved in medical, hospital, and investment management; ophthalmological research; sale of medical instruments and eyeglasses; cultural propagation; engineering renovation; and technology development. The company was formerly known as Chengdu Bright Eye Hospital Group Co., Ltd. and changed its name to Bright Eye Hospital Group Co., Ltd. in June 2025. Bright Eye Hospital Group Co., Ltd. was founded in 2005 and is headquartered in Chengdu, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOMr. Liang Jin
  • Employees5.02K
  • HeadquartersNo. 215, North Fourth Section of First Ring Road, Chengdu, China, 610084, China
  • Websitehttps://www.puruieyes.com

Leadership

  • Mr. Liang JinGM & Company Secretary · b. 1982
  • Mr. Guo Ping YangChief Financial Officer · b. 1980
  • Mr. Changliang CaoDeputy GM & Non-Independent Director · b. 1971
  • Mr. Ping HouDeputy GM & Non-Independent Director · b. 1973
  • Mr. Zhong Xiang LiuDeputy General Manager · b. 1971
  • Ms. Wen GaoDeputy General Manager · b. 1987
  • Wei Jia HanAccounting Supervisor

Financials

Income Statement

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.19B1.36B1.71B1.73B2.72B2.68B2.80B
Growth (%)-+14.21%+25.54%+0.91%+57.50%-1.46%+4.44%
Cost of Revenue684.15M773.63M968.35M1.01B1.52B1.69B1.79B
Gross Profit508.45M1.36B741.67M719.12M1.20B990.45M1.00B
Gross Margin42.63%100.00%43.37%41.67%44.00%36.98%35.91%
Operating Expense409.11M0548.43M613.74M816.73M887.29M861.90M
Operating Income99.34M1.36B193.24M105.37M379.10M103.15M142.64M
Operating Margin8.33%100.00%11.30%6.11%13.95%3.85%5.10%
EBITDA215.83M250.07M369.10M331.61M710.72M376.82M365.05M
EBITDA Margin18.10%18.36%21.58%19.22%26.15%14.07%13.05%
Net Income49.05M108.93M93.89M20.57M267.91M-101.86M-60.92M
Net Income Margin4.11%8.00%5.49%1.19%9.86%-3.80%-2.18%
R&D---6.64M11.03M8.02M10.82M
R&D as % of Total Revenue---0.39%0.41%0.30%0.39%
Interest Expense6.06M1.66M48.44M57.56M74.67M87.09M19.33M
Interest Expense % of Total Revenue0.51%0.12%2.83%3.34%2.75%3.25%0.69%

Balance Sheet

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets977.22M2.08B2.33B3.68B4.82B4.60B4.56B
Total Liabilities232.90M1.22B1.38B1.61B2.50B2.48B2.49B
Total Equity744.32M853.25M948.30M2.07B2.29B2.10B2.04B
Cash210.79M285.10M170.77M926.23M806.60M481.07M339.71M
Net Debt-----23.29M144.25M

Cash Flow

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow104.83M227.51M359.42M319.30M614.46M382.43M544.86M
Capital Expenditure245.97M146.60M254.80M327.99M626.87M542.86M226.41M
Free Cash Flow-141.14M227.51M104.62M-8.68M-12.41M-160.43M318.45M
Dividends Paid812.89K1.23M4.55M9.04M27.63M77.97M17.75M
FCF to OCF-134.63%100.00%29.11%-2.72%-2.02%-41.95%58.45%
Dividend Paid to FCF-0.58%0.54%4.35%-104.13%-222.68%-48.60%5.57%

Earnings

Report DateSep 30, 2022Mar 1, 2023Apr 26, 2023Aug 29, 2023Oct 29, 2023Apr 23, 2024Aug 27, 2024Oct 30, 2024Apr 28, 2025Aug 29, 2025Oct 28, 2025Apr 29, 2026Aug 31, 2026
EPS Estimate-------------
EPS Actual0.29-0.491.090.480.55-0.330.18-0.180.18-0.080.010.470.12
Surprise-------------
Timing---After-hoursPre-marketPre-marketPre-market-Pre-market----

Key Statistics & Ratios

Market Cap4.78B
Enterprise Value6.23B
Trailing P/E399.75
Forward P/E0.00
Price / Sales1.63
Price / Book2.22
EPS0.08
Book Value14.31
Revenue (TTM)2.94B
Gross Profit (TTM)1.22B
EBITDA349.01M
Profit Margin0.43%
Operating Margin7.92%
Return on Equity0.96%
Return on Assets2.70%
Shares Outstanding149.62M
Shares Float77.85M
Beta0.65
Dividend Yield0.94%
Dividend Rate0.30
Payout Ratio49.73%

Dividends

20261×
0.30Sep 11, 2026
20241×
0.40Jul 22, 2024
20231×
0.10Jul 17, 2023